Small cell carcinoma (SCC) of the gallbladder is an extremely rare tumor. Despite aggressive and varied treatments, its prognosis is poor. A 70-year-old woman undergoing treatment for pneumonia was detected with a gallbladder mass. Radical cholecystectomy was performed and the pathology revealed small cell carcinoma. There were metastases in 2 lymph nodes, scoring T2N1M0, stage IIIB (AJCC 7th). The patient has survived thus far, with subsequent chemotherapy. SCC of the gallbladder has an extremely low incidence and poor prognosis. In some cases, radical surgery with chemotherapy or radiation therapy could increase survival rate of patients. (Ann Hepatobiliary Pancreat Surg 2017;21:168-171)
INTRODUCTION
Small cell carcinoma (SCC) is an extremely rare tumor in the gallbladder (GB), that was first described by Albores-Saavedra et al. 1 To the researchers' knowledge, less than 100 cases have been published in English literature. Patients with this condition present with aggressive features and early metastasis. Due to the late stage presentation and highly malignant potential, the survival rate for SCC of the GB is low. The median survival time has been reported at nine months. 2 The treatment strategy is not clear, but patients with limited disease of the GB can be managed with multimodal therapy, which includes resection and chemoradiation. 3 Herein, this study presents a case of SCC of the GB in a patient, who survived for more than 75 months after resection and chemotherapy.
CASE
A 70-year-old had a gallstone which was identified two years prior. She had a mass in the GB, which was not accompanied by any symptoms. One month before admission, the patient was examined with computed tomography (CT) ( Reports about the management of SCC of the GB are scarce. Not only is it an extremely rare tumor, but the late stages at presentation due to its aggressiveness, also make it difficult to establish protocols for its management.
Surgery is the mainstay of GB cancer treatment, but it is unclear whether radical operations produce better outcomes for advanced stages of SCC. Groeschl et al. 
